These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9044874)

  • 1. Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging; a comparative study using different protocols.
    Bax JJ; Veening MA; Visser FC; van Lingen A; Heine RJ; Cornel JH; Visser CA
    Eur J Nucl Med; 1997 Jan; 24(1):35-41. PubMed ID: 9044874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac 18F-FDG-SPET studies in patients with non-insulin-dependent diabetes mellitus during hyperinsulinaemic euglycaemic clamping.
    Bax JJ; Visser FC; Raymakers PG; Van Lingen A; Cornel JH; Huitink JM; Elhendy A; Heine RJ; Visser CA
    Nucl Med Commun; 1997 Mar; 18(3):200-6. PubMed ID: 9106773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined hyperinsulinaemic glucose clamp and oral acipimox for optimizing metabolic conditions during 18F-fluorodeoxyglucose gated PET cardiac imaging: comparative results.
    Schröder O; Hör G; Hertel A; Baum RP
    Nucl Med Commun; 1998 Sep; 19(9):867-74. PubMed ID: 10581593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and feasibility of cardiac FDG SPECT following oral administration of Acipimox, a nicotinic acid derivative: Comparison of image quality with hyperinsulinemic euglycemic clamping in nondiabetic patients.
    Bax JJ; Visser FC; Poldermans D; Van Lingen A; Elhendy A; Boersma E; Sloof GW; Visser CA
    J Nucl Cardiol; 2002; 9(6):587-93. PubMed ID: 12466782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of myocardial [fluorine-18]fluorodeoxyglucose uptake by a nicotinic acid derivative.
    Knuuti MJ; Yki-Järvinen H; Voipio-Pulkki LM; Mäki M; Ruotsalainen U; Härkönen R; Teräs M; Haaparanta M; Bergman J; Hartiala J; Wegelius U; Nuutila P
    J Nucl Med; 1994 Jun; 35(6):989-98. PubMed ID: 8195886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility, safety and image quality of cardiac FDG studies during hyperinsulinaemic-euglycaemic clamping.
    Bax JJ; Visser FC; Poldermans D; van Lingen A; Elhendy A; Boersma E; Visser CA
    Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):452-7. PubMed ID: 11914881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simplified intravenous glucose loading protocol for fluorine-18 fluorodeoxyglucose cardiac single-photon emission tomography.
    Martin WH; Jones RC; Delbeke D; Sandler MP
    Eur J Nucl Med; 1997 Oct; 24(10):1291-7. PubMed ID: 9323271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ECG-triggered 18F-fluorodeoxyglucose positron emission tomography imaging of the rat heart is dramatically enhanced by acipimox.
    Poussier S; Maskali F; Tran N; Person C; Maureira P; Boutley H; Karcher G; Lacolley P; Régnault V; Fay R; Marie PY
    Eur J Nucl Med Mol Imaging; 2010 Aug; 37(9):1745-50. PubMed ID: 20393712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility and image quality of dual-isotope SPECT using 18F-FDG and (99m)Tc-tetrofosmin after acipimox administration.
    Kam BL; Valkema R; Poldermans D; Bax JJ; Reijs AE; Rambaldi R; Boersma E; Rietveld T; Roelandt JR; Krenning EP
    J Nucl Med; 2003 Feb; 44(2):140-5. PubMed ID: 12571201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of high and low plasma insulin levels on the uptake of fluorine-18 fluorodeoxyglucose in myocardium and femoral muscle, assessed by planar imaging.
    Huitink JM; Visser FC; van Leeuwen GR; van Lingen A; Bax JJ; Heine RJ; Teule GJ; Visser CA
    Eur J Nucl Med; 1995 Oct; 22(10):1141-8. PubMed ID: 8542898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial metabolic imaging by means of fluorine-18 deoxyglucose/technetium-99m sestamibi dual-isotope single-photon emission tomography.
    Stoll HP; Hellwig N; Alexander C; Ozbek C; Schieffer H; Oberhausen E
    Eur J Nucl Med; 1994 Oct; 21(10):1085-93. PubMed ID: 7828618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of myocardial uptake of fluorine-18-fluorodeoxyglucose imaged with PET and SPECT in dyssynergic myocardium.
    Bax JJ; Visser FC; Blanksma PK; Veening MA; Tan ES; Willemsen TM; van Lingen A; Teule GJ; Vaalburg W; Lie KI; Visser CA
    J Nucl Med; 1996 Oct; 37(10):1631-6. PubMed ID: 8862297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between myocardial uptake of thallium-201 chloride and fluorine-18 fluorodeoxyglucose imaged with single-photon emission tomography in normal individuals.
    Bax JJ; Visser FC; van Lingen A; Groeneveld AB; Huitink JM; Teule GJ; Visser CA
    Eur J Nucl Med; 1995 Jan; 22(1):56-60. PubMed ID: 7698156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of assessing regional myocardial uptake of 18F-fluorodeoxyglucose using single photon emission computed tomography.
    Bax JJ; Visser FC; van Lingen A; Huitink JM; Kamp O; van Leeuwen GR; Visser GW; Teule GJ; Visser CA
    Eur Heart J; 1993 Dec; 14(12):1675-82. PubMed ID: 8131767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acipimox does not augment thallium-201 redistribution in the fasting state.
    Gunning MG; Clunie G; Yepes-Mora S; Eastick S; Underwood SR; Bomanji J; Ell PJ
    J Nucl Cardiol; 1999; 6(6):620-5. PubMed ID: 10608589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction.
    Vitale GD; deKemp RA; Ruddy TD; Williams K; Beanlands RS
    J Nucl Med; 2001 Dec; 42(12):1730-6. PubMed ID: 11752067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography.
    Knuuti MJ; Nuutila P; Ruotsalainen U; Saraste M; Härkönen R; Ahonen A; Teräs M; Haaparanta M; Wegelius U; Haapanen A
    J Nucl Med; 1992 Jul; 33(7):1255-62. PubMed ID: 1613561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic imaging using F18-fluorodeoxyglucose to assess myocardial viability.
    Bax JJ; Visser FC; van Lingen A; Cornel JH; Fioretti PM; van der Wall EE
    Int J Card Imaging; 1997 Apr; 13(2):145-55; discussion 157-60. PubMed ID: 9110194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncoupling of fatty acid and glucose metabolism in malignant lymphoma: a PET study.
    Nuutinen J; Minn H; Bergman J; Haaparanta M; Ruotasalainen U; Laine H; Knuuti J
    Br J Cancer; 1999 May; 80(3-4):513-8. PubMed ID: 10408861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial F-18 fluorodeoxyglucose imaging by SPECT.
    Bax JJ; Visser FC; van Lingen A; Visser CA; Teule GJ
    Clin Nucl Med; 1995 Jun; 20(6):486-90. PubMed ID: 7648727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.